109 related articles for article (PubMed ID: 19639897)
1. Effect of patient medication cost share on adherence and glycemic control.
Hunt J; Rozenfeld Y; Shenolikar R
Manag Care; 2009 Jul; 18(7):47-53. PubMed ID: 19639897
[TBL] [Abstract][Full Text] [Related]
2. Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.
Gibson TB; Jing Y; Kim E; Bagalman E; Wang S; Whitehead R; Tran QV; Doshi JA
Manag Care; 2010 Aug; 19(8):40-7. PubMed ID: 20822071
[TBL] [Abstract][Full Text] [Related]
3. Impact of statin copayments on adherence and medical care utilization and expenditures.
Gibson TB; Mark TL; Axelsen K; Baser O; Rublee DA; McGuigan KA
Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486
[TBL] [Abstract][Full Text] [Related]
4. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
Cheong C; Barner JC; Lawson KA; Johnsrud MT
Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
[TBL] [Abstract][Full Text] [Related]
5. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
Kalsekar I; Sheehan C; Peak A
Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus.
Chao J; Nau DP; Aikens JE
Clin Ther; 2007 Jan; 29(1):177-80. PubMed ID: 17379058
[TBL] [Abstract][Full Text] [Related]
7. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.
Hauber AB; Mohamed AF; Johnson FR; Falvey H
Diabet Med; 2009 Apr; 26(4):416-24. PubMed ID: 19388973
[TBL] [Abstract][Full Text] [Related]
8. The effects of prescription drug copayments on statin adherence.
Gibson TB; Mark TL; McGuigan KA; Axelsen K; Wang S
Am J Manag Care; 2006 Sep; 12(9):509-17. PubMed ID: 16961440
[TBL] [Abstract][Full Text] [Related]
9. Oral antidiabetic medication adherence and glycemic control in managed care.
Rozenfeld Y; Hunt JS; Plauschinat C; Wong KS
Am J Manag Care; 2008 Feb; 14(2):71-5. PubMed ID: 18269302
[TBL] [Abstract][Full Text] [Related]
10. In chronic disease, nationwide data show poor adherence by patients to medication and by physicians to guidelines.
Thier SL; Yu-Isenberg KS; Leas BF; Cantrell CR; DeBussey S; Goldfarb NI; Nash DB
Manag Care; 2008 Feb; 17(2):48-52, 55-7. PubMed ID: 18361259
[TBL] [Abstract][Full Text] [Related]
11. Cost sharing, adherence, and health outcomes in patients with diabetes.
Gibson TB; Song X; Alemayehu B; Wang SS; Waddell JL; Bouchard JR; Forma F
Am J Manag Care; 2010 Aug; 16(8):589-600. PubMed ID: 20712392
[TBL] [Abstract][Full Text] [Related]
12. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
[TBL] [Abstract][Full Text] [Related]
13. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
Berger J
Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934
[TBL] [Abstract][Full Text] [Related]
14. A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses.
Gibson TB; Wang S; Kelly E; Brown C; Turner C; Frech-Tamas F; Doyle J; Mauceri E
Health Aff (Millwood); 2011 Jan; 30(1):109-17. PubMed ID: 21209446
[TBL] [Abstract][Full Text] [Related]
15. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
Balu S; Simko RJ; Quimbo RM; Cziraky MJ
Curr Med Res Opin; 2009 Nov; 25(11):2765-75. PubMed ID: 19785511
[TBL] [Abstract][Full Text] [Related]
16. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
[TBL] [Abstract][Full Text] [Related]
17. Refill adherence to oral antihyperglycaemic drugs in Sweden.
Haupt D; Weitoft GR; Nilsson JL
Acta Diabetol; 2009 Sep; 46(3):203-8. PubMed ID: 19023514
[TBL] [Abstract][Full Text] [Related]
18. Impact of decreasing copayments on medication adherence within a disease management environment.
Chernew ME; Shah MR; Wegh A; Rosenberg SN; Juster IA; Rosen AB; Sokol MC; Yu-Isenberg K; Fendrick AM
Health Aff (Millwood); 2008; 27(1):103-12. PubMed ID: 18180484
[TBL] [Abstract][Full Text] [Related]
19. Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea.
Hong JS; Kang HC
Med Care; 2011 Apr; 49(4):378-84. PubMed ID: 21368684
[TBL] [Abstract][Full Text] [Related]
20. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
